In addition, qRT-PCR and IHC staining showed that the expression of LDHA was significantly declined in combination group, establishing that PRMT5 blockade can inhibit the growth of colorectal cancer via the LDHA regulation (Fig. 6 E–G). Here, LDHA is linked to colorectal cancer.